{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:33:03Z","timestamp":1786120383370,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4,1]]},"DOI":"10.1097\/qai.0b013e318249de59","type":"journal-article","created":{"date-parts":[[2012,1,20]],"date-time":"2012-01-20T05:08:06Z","timestamp":1327036086000},"page":"360-367","source":"Crossref","is-referenced-by-count":37,"title":["Plasma HIV-RNA Is the Key Determinant of Long-Term Antibody Persistence After Yellow Fever Immunization in a Cohort of 364 HIV-Infected Patients"],"prefix":"10.1097","volume":"59","author":[{"given":"J\u00e9r\u00f4me","family":"Pacanowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Campa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Dabrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Dominique","family":"Poveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Meynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Poirot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Fonquernie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Marie","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210131","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/jama.1996.03540140045025","article-title":". Yellow fever: a decade of reemergence.","volume":"276","author":"Robertson","year":"1996","journal-title":"JAMA"},{"key":"R2-7-20210131","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1001\/jama.300.8.960","article-title":"Yellow fever: 100 years of discovery.","volume":"300","author":"Staples","year":"2008","journal-title":"JAMA"},{"key":"R3-7-20210131","first-page":"895","article-title":". Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine.","volume":"59","author":"Poland","year":"1981","journal-title":"Bull World Health Organ"},{"key":"R4-7-20210131","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":". Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events.","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"key":"R5-7-20210131","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/hiv.09.52","article-title":". Yellow fever vaccination in HIV-infected patients.","volume":"4","author":"Veit","year":"2010","journal-title":"HIV Ther"},{"key":"R6-7-20210131","first-page":"131","article-title":"Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection.","volume":"85","author":"Kengsakul","year":"2002","journal-title":"J Med Assoc Thailand (Chotmaihet thangphaet)"},{"key":"R9-7-20210131","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/00006454-199712000-00015","article-title":". Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1.","volume":"16","author":"Sibailly","year":"1997","journal-title":"Pediatr infect Dis J"},{"key":"R10-7-20210131","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1086\/314031","article-title":". Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases.","volume":"31","author":"Receveur","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R11-7-20210131","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/00002030-200403260-00020","article-title":". Yellow fever vaccine is safe and effective in HIV-infected patients.","volume":"18","author":"Tattevin","year":"2004","journal-title":"AIDS"},{"key":"R12-7-20210131","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2174\/157016210793499277","article-title":". Immunogenicity and tolerability of yellow fever vaccination in 23 French HIV-infected patients.","volume":"8","author":"Pistone","year":"2010","journal-title":"Curr HIV Res"},{"key":"R13-7-20210131","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/597006","article-title":". Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients.","volume":"48","author":"Veit","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R14-7-20210131","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","article-title":". Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA.","volume":"4","author":"Niedrig","year":"1999","journal-title":"Trop Med Int Health"},{"key":"R15-7-20210131","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4269\/ajtmh.1999.60.1045","article-title":". Comparison of the immunogenicity and safety of two 17D yellow fever vaccines.","volume":"60","author":"Lang","year":"1999","journal-title":"Am J Trop Med Hygiene"},{"key":"R16-7-20210131","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2893.2006.00822.x","article-title":". Predictors of immunity after hepatitis A vaccination in HIV-infected persons.","volume":"14","author":"Overton","year":"2007","journal-title":"J Viral Hepat"},{"issue":"suppl 10A","key":"R17-7-20210131","doi-asserted-by":"crossref","first-page":"75S","DOI":"10.1016\/j.amjmed.2005.07.024","article-title":"Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus.","volume":"118","author":"Laurence","year":"2005","journal-title":"Am J Med"},{"key":"R18-7-20210131","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1086\/433180","article-title":". Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons.","volume":"41","author":"Overton","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R19-7-20210131","doi-asserted-by":"crossref","first-page":"E77","DOI":"10.1016\/j.ijid.2008.05.1226","article-title":"Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.","volume":"12","author":"Bailey","year":"2008","journal-title":"Int J Infect Dis"},{"key":"R20-7-20210131","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1016\/j.vaccine.2007.09.052","article-title":". Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.","volume":"25","author":"Puthanakit","year":"2007","journal-title":"Vaccine"},{"key":"R21-7-20210131","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1067\/mpd.2001.115972","article-title":". Immunization of HIV-infected children with varicella vaccine.","volume":"139","author":"Levin","year":"2001","journal-title":"J Pediatr"},{"key":"R22-7-20210131","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/598193","article-title":". Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients.","volume":"48","author":"Evison","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R23-7-20210131","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1468-1293.2009.00744.x","article-title":". A 5-year longitudinal follow-up study of serological responses to 23-valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy.","volume":"11","author":"Hung","year":"2010","journal-title":"HIV Med"},{"key":"R24-7-20210131","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.vaccine.2005.12.055","article-title":". Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine.","volume":"24","author":"Hepburn","year":"2006","journal-title":"Vaccine"},{"key":"R25-7-20210131","doi-asserted-by":"crossref","first-page":"e1993","DOI":"10.1371\/journal.pone.0001993","article-title":". Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial.","volume":"3","author":"Roukens","year":"2008","journal-title":"PloS One"},{"key":"R26-7-20210131","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":". Human effector and memory CD8 T cell responses to smallpox and yellow fever vaccines.","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity"},{"key":"R27-7-20210131","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1086\/590187","article-title":". Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes.","volume":"198","author":"Pulendran","year":"2008","journal-title":"J Infect Dis"},{"key":"R28-7-20210131","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/QAD.0b013e328323aeb4","article-title":"A note of caution on yellow fever vaccination during maraviroc treatment: a hypothesis on a potential dangerous interaction.","volume":"23","author":"Roukens","year":"2009","journal-title":"AIDS"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201204010-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:30:06Z","timestamp":1786048206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201204010-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,1]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318249de59","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4,1]]}}}